Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC

CONCLUSIONS: Our findings indicate the miR-181a-5p and miR-630 expression levels have the potential to prognose and predict and therefore improve the treatment individualization and the outcome of NSCLC patients. Circulating miR-181a-5p has the potential clinical value as a non-invasive biomarker for NSCLC.PMID:37697308 | DOI:10.1186/s12885-023-11365-5

Source: Cancer Control - September 11, 2023 Category: Cancer & Oncology Authors: Julija Simiene Daiva Dabkeviciene Diana Stanciute Rimvile Prokarenkaite Valerija Jablonskiene Renatas Askinis Kamile Normantaite Saulius Cicenas Kestutis Suziedelis Source Type: research